Evidence map›Paper›PMID 24605828›Full record

ArticleEndocrinology2014

Activated AKT pathway promotes establishment of endometriosis.

Tae Hoon Kim, Yanni Yu, Lily Luo, John P Lydon, Jae-Wook Jeong, J Julie Kim

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Transgenic mice applications in the study of endometriosis pathogenesis.Frontiers in cell and developmental biology · 2024
    Review
  14. Review
  15. Strategies for modelling endometrial diseases.Nature reviews. Endocrinology · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. The Role of mTOR and eIF Signaling in Benign Endometrial Diseases.International journal of molecular sciences · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Tae Hoon KimDepartment of Obstetrics, Gynecology, and Reproductive Biology (T.H.K., J.-W.J.), Michigan State University, College of Human Medicine, Grand Rapids, Michigan 49503; Division of Reproductive Biology Research (Y.Y., L.L., J.J.K.), Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, 60611; and Department of Molecular and Cellular Biology (J.P.L.), Baylor College of Medicine, Houston, Texas 77030.
Yanni Yu
Lily Luo
John P Lydon
Jae-Wook Jeong
J Julie Kim
Northwestern University · USMichigan State University · USBaylor College of Medicine · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9M
TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTIONU54HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI MATZUK, MARTIN M. · 1998 to 2013
$19.9M
Regulation of IGFBP-1 by FKHR and HOXA10 in pregnancyR01HD044715 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KIM, JI-YONG JULIE · 2003 to 2010
$1.8M
Steroid Hormone Regulation of Uterine Function and DysfunctionR01HD057873 · NICHD · MICHIGAN STATE UNIVERSITY · PI JEONG, JAE-WOOK · 2008 to 2012
$1.3M
NCI NIH HHS P30 CA060553NICHD NIH HHS R01 HD044715NICHD NIH HHS R01HD044715NICHD NIH HHS R01 HD057873NICHD NIH HHS R01HD057873NICHD NIH HHS U54 HD007495NICHD NIH HHS U54 HD07495
6 · The paper itself

Abstract

The pathogenesis of endometriosis remains unclear, and relatively little is known about the mechanisms that promote establishment and survival of the disease. Previously, we demonstrated that v-akt murine thymoma viral oncogene homolog (AKT) activity was increased in endometriosis tissues and cells from ovarian endometriomas and that this increase promoted cell survival as well as decreased levels of progesterone receptor. The objective of this study was to demonstrate a role for AKT in the establishment of ectopic lesions. First, a dose-dependent inhibition of AKT in stromal cells from human ovarian endometriomas (OSIS) as well as endometrial stromal cells from disease-free patients (ESC) with the allosteric AKT inhibitor MK-2206 was demonstrated by decreased levels of phosphorylated (p)(Ser473)-AKT. Levels of the AKT target protein, p(Ser256)-forkhead box O1 were increased in OSIS cells, which decreased with MK-2206 treatment, whereas levels of p(Ser9)-glycogen synthase kinase 3β did not change in response to MK-2206. Although MK-2206 decreased viability of both OSIS and ESC in a dose-dependent manner, proliferation of OSIS cells was differentially decreased significantly compared with ESC. Next, the role of hyperactive AKT in the establishment of ectopic lesions was studied using the bigenic, PR(cre/+)Pten(f/+) heterozygous mouse. Autologous implantation of uterine tissues was performed in these mice. After 4 weeks, an average of 4 ± 0.33 lesions per Pten(f/+) mouse and 7.5 ± 0.43 lesions in the PR(cre/+)Pten(f/+) mouse were found. Histological examination of the lesions showed endometrial tissue-like morphology, which was similar in both the Pten(f/+) and PR(cre/+)Pten(f/+) mice. Treatment of mice with MK-2206 resulted in a significantly decreased number of lesions established. Immunohistochemical staining of ectopic lesions revealed decreased p(Ser473)-AKT and the proliferation marker Ki67 from MK-2206-treated mice compared with vehicle-treated mice. Furthermore, levels of FOXO1 and progesterone receptor increased in lesions of mice receiving MK-2206. These results demonstrate that heightened AKT activity plays an active role in the establishment of ectopic endometrial tissues.

Indexed as

Disease Models, AnimalSignal TransductionAnimalsCell ProliferationCells, CulturedCell SurvivalCrosses, GeneticEndometriosisEndometriumFemaleForkhead Box Protein O1Forkhead Transcription FactorsHeterocyclic Compounds, 3-RingHumansMiceMice, TransgenicAKT1 protein, humanAkt1 protein, mouseForkhead Box Protein O1Forkhead Transcription FactorsFOXO1 protein, humanFoxo1 protein, mouseHeterocyclic Compounds, 3-RingMK 2206Protein Kinase InhibitorsProto-Oncogene Proteins c-akt

Identifiers

PMID24605828
PMCPMC3990849
OpenAlexW2171332620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.